(Q34448865)

English

Ripasudil: first global approval

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

title

Ripasudil: first global approval (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 August 2017

1

Karly P Garnock-Jones

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

publication date

1 December 2014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

volume

74

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

issue

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

page(s)

2211-2215

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

cites work

Pharmacological management of ocular hypertension: current approaches and future prospective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS40265-014-0333-2

retrieved

21 January 2018

Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS40265-014-0333-2

retrieved

21 January 2018

Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS40265-014-0333-2

retrieved

21 January 2018

The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS40265-014-0333-2

retrieved

21 January 2018

Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS40265-014-0333-2

retrieved

21 January 2018

Identifiers

DOI

10.1007/S40265-014-0333-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

Dimensions Publication ID

1032502680

0 references

PubMed publication ID

25414122

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25414122

retrieved

2 August 2017

(Q34448865)

Ripasudil: first global approval

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)